Key result
Comorbid hypothyroidism linked to ~4-fold higher in-hospital mortality in CHF patients with MDD.
Why the study?
Does comorbid major depressive disorder affect hospital stay, cost, and in-hospital mortality in hospitalized congestive heart failure patients?
Cross-Sectional (n=21,165)
Yes
Does comorbid major depressive disorder affect hospital stay, cost, and in-hospital mortality in hospitalized congestive heart failure patients?
Odds Ratio: 4.405 (95% CI 2.329–8.333)
p-value: p=<0.001
Comorbid depression, particularly with concurrent hypothyroidism or substance abuse, significantly increases hospital length of stay, costs, and in-hospital mortality in patients hospitalized for heart failure.
Hypothyroidism may flag higher mortality risk in depressed HF inpatients; this observational link is hypothesis-generating and requires prospective confirmation.
Objective To evaluate the demographic predictors of major depressive disorder (MDD) in hospitalized congestive heart failure (CHF) patients and measure the differences in hospital stay and cost per comorbidities and the associated risk of in-hospital mortality. Methods This retrospective cross-sectional study used nationwide inpatient data from the healthcare cost and utilization project (HCUP). We identified patients with CHF as the primary diagnosis and MDD as the secondary diagnosis using ICD-9-CM codes and compared with the CHF patient without MDD. The differences in comorbidities were quantified using chi-square tests and the logistic regression model was used to evaluate mortality risk among comorbidities using odds ratio (OR). Results Elder CHF patients, 36-50-year-old (OR: 1.324) and whites (OR: 1.673), have a higher likelihood of a co-diagnosis of MDD. Females with heart failure have two-fold higher odds of MDD (OR: 2.332). Majority of the medical comorbidities were seen in a higher proportion of CHF patients without MDD. Hypothyroidism (10.2%) and drug abuse (15.2%) were seen more in depressed patients comparatively. Among substance use disorder, patients with drug abuse stayed longer and had a higher hospitalization total cost ($51,828). And, hypothyroidism was associated with longer inpatient stay (5.6 days) and cost ($64,726), and four-fold higher odds of in-hospital mortality (OR: 4.405). Though alcohol abuse was seen only in 7.4% of CHF patients with MDD, it was associated with the three-fold higher likelihood of deaths during hospitalization (OR: 3.195). Conclusion A middle-aged, white female with comorbid depression has a higher risk of hospitalization for heart failure. Depressed CHF patients with comorbid hypothyroidism were hospitalized for a longer duration with higher inpatient cost and four times higher risk of mortality during hospitalization stay. Further studies are required to evaluate the underlying cause of worse hospital outcomes in depressed CHF patients with alcohol abuse and hypothyroidism. An integrated healthcare model is required for early diagnosis and treatment of depression and associated comorbidities in CHF patients to reduce mortality and improve post-CHF outcomes.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2018) conducted a cross-sectional in Congestive heart failure (CHF) with major depressive disorder (MDD) (n=21,165). Comorbid hypothyroidism vs. Without comorbid hypothyroidism was evaluated on In-hospital mortality among CHF patients with MDD (OR 4.405, 95% CI 2.329-8.333, p=<0.001). In hospitalized heart failure patients with major depressive disorder, comorbid hypothyroidism was associated with a four-fold higher risk of in-hospital mortality (OR 4.405).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: